20 completed, 2 withdrawn, 1 unknown. 23 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 23 | Completed 20, Withdrawn 2, Unknown 1 |
| Phase 3 | 3 | Completed 3 |
Follow Cellulitis: new trials by email Literature Review of Cellulitis trials Research Report on Cellulitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections 9MW1411 injection 1 combined with Linezolid, 9MW1411 injection 2 combined with Linezolid, 9MW1411 injection placebo combined with Linezolid - Skin Infection | Phase 2 | Unknown | Mabwell (Shanghai) Bioscience Co., Ltd. | 90 | 2022-02-16 | 2022-04-21 |
| Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment TMP-SMX, DOXY - Methicillin-resistant Staphylococcus Aureus, Skin Infection | Phase 2 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 269 | 2018-11-26 | 2025-12-04 |
| The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. iontophoresis + caffeine - Caffeine, Cellulitis | Phase 2 / Phase 3 | Completed | Universidade Norte do Paraná | 30 | 2018-06-14 | 2019-04-16 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections Daptomycin, Brilacidin - Skin Infection, Bacterial Infection | Phase 2 | Completed | Cellceutix Corporation | 215 | 2014-02-01 | 2018-09-26 |
| Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus CG400549 - Skin Infection | Phase 2 | Completed | CrystalGenomics, Inc. | 20 | 2012-06-01 | 2022-09-10 |
| Evaluation of Novel Antimicrobial Hand Towels Antimicrobial Hand Towel - Diarrheal Diseases, Acute Respiratory Infections | Phase 2 / Phase 3 | Completed | Centers for Disease Control and Prevention | 449 | 2012-03-01 | 2015-07-31 |
| A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study TR701 FA - Major Cutaneous Abscess, Cellulitis | Phase 2 | Completed | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 200 | 2012-02-15 | 2018-08-29 |
| A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci AFN-12520000 - Skin and Subcutaneous Tissue Bacterial Infections, Wound Infection | Phase 2 | Completed | Affinium Pharmaceuticals, Ltd | 103 | 2012-02-01 | 2012-08-07 |
| Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). ACZ885 - TNF-receptor Associated Periodic Syndromes (TRAPS) | Phase 2 | Completed | Novartis Pharmaceuticals | 20 | 2010-10-01 | 2016-02-04 |
| A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection LTX-109 - Gram-positive, Skin Infections, Mild Eczema/Dermatoses | Phase 2 | Completed | Lytix Biopharma AS | 24 | 2010-09-01 | 2011-02-16 |
| GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection GSK1322322, Linezolid, GSK1322322 placebo - Skin Infections, Bacterial | Phase 2 | Completed | GlaxoSmithKline | 84 | 2010-08-17 | 2017-12-04 |
| Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) JNJ-32729463, linezolid, JNJ-32729463 placebo - Complicated Skin and Skin Structure Infections | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 161 | 2010-06-01 | 2011-12-16 |
| Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis IV cefazolin plus oral probenecid and placebo cephalexin, Oral cephalexin and saline IV plus probenecid placebo - Cellulitis | Phase 2 | Completed | Kelowna General Hospital | 206 | 2010-05-01 | 2018-08-13 |
| The Use of Oral Steroids in the Treatment of Cellulitis Prednisone, Placebo Oral Tablet - Cellulitis, Erysipelas | Phase 2 | Withdrawn | Milton S. Hershey Medical Center | 2010-01-15 | 2017-07-25 | |
| Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Trimethoprim-sulfamethoxazole, Placebo, Clindamycin - Staphylococcal Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1310 | 2009-04-01 | 2016-03-17 |
| Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection PZ-601, Standard of Care - Skin Infections | Phase 2 | Completed | Protez Pharmaceuticals, Inc. | 99 | 2008-05-01 | 2009-06-03 |
| Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage Type of dressing - Iodoform, Type of dressing - Aquacel - Abscess, Cellulitis | Phase 2 | Completed | Valleywise Health | 92 | 2008-03-01 | 2017-10-04 |
| Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections ceftaroline, linezolid, Aztreonam - Bacterial Infection | Phase 2 | Completed | Forest Laboratories | 150 | 2008-02-01 | 2017-03-14 |
| A Study for Patients With Complicated Skin and Skin Structure Infections oritavancin - Staphylococcal Skin Infections, Wounds and Injuries | Phase 2 | Completed | Targanta Therapeutics Corporation | 294 | 2007-08-01 | 2008-08-14 |
| Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Telavancin, vancomycin or antistaphylococcal penicillin - Infections, Gram-positive Bacterial | Phase 2 | Completed | Cumberland Pharmaceuticals | 201 | 2004-02-01 | 2019-01-16 |
Showing 20 of 23. Sign in to see all of them.
Abscess (8) · Wound Infection (6) · Bacterial Infections (3) · Erysipelas (3) · Gram-Positive Bacterial Infections (3) · Skin Diseases (3) · Burns (2) · Fever (2) · Skin Diseases, Infectious (2) · Staphylococcal Infections (2) · Ulcer (2) · Abdominal Pain (1) · Dermatitis, Atopic (1) · Emergencies (1)
Connective Tissue Diseases (23) · Pathological Conditions, Signs and Symptoms (23) · Skin and Connective Tissue Diseases (23) · Infections (22) · Inflammation (22) · Pathologic Processes (22) · Suppuration (22) · Skin Diseases, Infectious (20) · Bacterial Infections and Mycoses (12) · Bacterial Infections (8) · Gram-Positive Bacterial Infections (6) · Skin Diseases (6) · Skin Diseases, Bacterial (5) · Streptococcal Infections (4) · Body Temperature Changes (2)
Linezolid (4) · Trimethoprim, Sulfamethoxazole Drug Combination (2) · Vancomycin (2) · telavancin (2) · API 1252 (1) · Aztreonam (1) · CG 400549 (1) · Caffeine (1) · Cefazolin (1) · Ceftaroline (1) · Cephalexin (1) · Clindamycin (1) · Daptomycin (1) · Doxycycline (1) · GSK1322322 (1)
Cumberland Pharmaceuticals (2) · Affinium Pharmaceuticals, Ltd (1) · Cellceutix Corporation (1) · Centers for Disease Control and Prevention (1) · CrystalGenomics, Inc. (1) · Forest Laboratories (1) · Furiex Pharmaceuticals, Inc (1) · GlaxoSmithKline (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Kelowna General Hospital (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Lytix Biopharma AS (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1) · Merz North America, Inc. (1) · Milton S. Hershey Medical Center (1)
United States (14) · Canada (2) · Italy (2) · Australia (1) · Brazil (1) · China (1) · Hungary (1) · India (1) · Ireland (1) · Romania (1) · Ukraine (1) · United Kingdom (1)
G. Ralph Corey, MD (2) · Barry Hafkin, MD (1) · Dawn Dalen, PharmD (1) · Fritz Stephanie, MD, MSCI, FAAP, FIDSA, FPIDS (1) · Jeffrey S. Overcash, MD (1) · Lajos Kemeny, DSc, Prof (1) · Loren G Miller, MD, MPH (1) · Madhumita Sinha, MD (1) · Michael Kuligowski, MD (1) · Peter Zed, PharmD (1) · Philippe Prokocimer, MD (1)
PMID 19220646, PMID 21537018, PMID 24010809, PMID 25136015, PMID 25785967, PMID 26711777, PMID 27269295, PMID 27474763, PMID 27530088, PMID 28657870, PMID 29914924